BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2011
View Archived Issues
Merck & Co. presents new glucagon receptor antagonist for type 2 diabetes
Read More
Betulin shows potential for the treatment of metabolic syndrome
Read More
Bellicum granted award to support CaspaCIDe cancer therapy
Read More
New dual LFA-1/MAC-1 antagonists presented by Roche at the ACS meeting
Read More
Dainippon Sumitomo and Intercept sign licensing agreement for obeticholic acid
Read More
OriBase Pharma identifies agent for BCR/ABL T315I mutant CML
Read More
Cellzome patents new series of compounds that inhibit JAK3
Read More
SMO inhibitors reported by Pfizer for use in cancer
Read More
New steroid sulfatase/aromatase inhibitors reported by Sterix
Read More
Ark Therapeutics presents new neuropilin-1 antagonists
Read More
PHOENIX trial of PHP in distributive shock to continue after interim analysis
Read More
European Commission approves retigabine for partial onset seizures
Read More
ViroPharma begins phase II Cinryze study for antibody-mediated rejection
Read More
Gilead Sciences and Yale to collaborate on cancer research
Read More
Phase IIb trial of Pharmasset's PSI-7977 for multiple HCV genotypes begins
Read More
Phase II trial compares MDV-3100 with bicalutamide in advanced prostate cancer
Read More
Valeant Pharmaceuticals proposes to acquire Cephalon
Read More
Merck Serono applies for E.U. indication extension for Erbitux for advanced or metastatic NSCLC
Read More
Dainippon Sumitomo and Takeda sign agreement for lurasidone in Europe
Read More
Natco Pharma receives FDA orphan drug status for NRC-AN-019
Read More
Amgen and Takeda report topline phase II results for motesanib in lung cancer
Read More
U.S. Department of Defense and Cytos Biotechnology collaborate on malaria vaccines research
Read More
Eli Lilly launches Axiron topical testosterone replacement therapy in the U.S.
Read More
Alzheimer's Drug Discovery Foundation to fund Prana's PBT-2 phase II trial
Read More
Composite iMyD88/CD40 fusion protein shows enhanced antitumor activity
Read More
